Pharmaceutical Drug Delivery Market - By Route Of Administration, By Application, Facility Of Use

Description

Global Pharmaceutical Drug Delivery Market size will garner commendable gains through 2032. Surging incidences of chronic diseases such as diabetes, cardiovascular diseases, and arthritis have resulted in increased mortality rates. As per WHO, cardiovascular diseases account for around 17.9 million deaths every year globally. In this regard, many healthcare organizations and pharmaceutical companies are investing notable amounts to boost the efficacy of the medication and its route of administration, creating a broad scope for industry growth.

The overall pharmaceutical drug delivery market is classified into application, route of administration, facility of use, and region.

With respect to the route of administration, the industry share from the oral drug delivery market size will register recognizable growth through 2032. Rising prevalence of infectious, inflammatory, gastrointestinal diseases, and others has increased the demand for oral administration. Moreover, this route of drug administration is also cost-effective and convenient for the elderly and children.

Based on application, the pharmaceutical drug delivery market from the cancer segment will grow at over 8.5% by 2032. Increasing incidences of cancer have increased investments in introducing new pharmaceutical drug delivery methods. Many pharmaceutical companies and healthcare organizations across the globe are investing substantial amounts into cancer research which will also positively affect segment expansion. To illustrate, in March 2023, Pfizer Inc., an American multinational pharmaceutical company, announced over USD 43 billion in cancer research.

Based on the facility of use, the industry is classified into ambulatory surgical centers and clinics, hospitals, home care settings, diagnostic centers, and other facilities of use. The pharmaceutical drug delivery industry from the home care settings segment will grow at more than 7.5% CAGR from 2023 to 2032. Growing geriatric population base and its susceptibility to chronic diseases will support segment growth. Additionally, the high cost-effectiveness of home care settings favors their adoption.

On the regional front, the Asia Pacific pharmaceutical drug delivery industry share will grow at a substantial CAGR from 2023 to 2032. Growing R&D investments by industry players in product innovations are contributing to regional growth. Moreover, the governments across several regional economies are also investing significant amounts into expanding the healthcare infrastructure, which will further work towards regional expansion. As per Invest India, the healthcare industry in India has the potential to reach USD 188 billion by 2030.

Product Code: 5565

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope and definitions
1.3 Base estimates and working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Pharmaceutical drug delivery industry 360 degree synopsis, 2018 - 2032
2.2 Business trends
2.3 Route of administration trends
2.4 Application trends
2.5 Facility of use trends
2.6 Regional trends

Chapter 3 Pharmaceutical Drug Delivery Market Insights

3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Rising prevalence of chronic diseases
  - 3.3.1.2 Growth in the biologics market
  - 3.3.1.3 Technological advancement and new product launches
  - 3.3.1.4 Increasing investment in pharmaceutical R&D
  - 3.3.1.5 Self-administration and home care
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Risk of needlestick injuries

.3.3.2.2. Cost intensive drug development process

3.4 Growth potential analysis
- 3.4.1 By route of administration
- 3.4.2 By application
- 3.4.3 By facility of use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 PESTLE Analysis

Chapter 4 Competitive landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix, 2022
4.4 Company market share analysis, 2022
4.5 Strategic outlook matrix, 2022
4.6 Strategy dashboard, 2022

Chapter 5 Pharmaceutical Drug Delivery Market, By Route of Administration

5.1 Key segment trends
5.2 Oral drug delivery
- 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.2.2 Solid oral drugs
  - 5.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.2.2 Tablets
    - 5.2.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.2.3 Capsules
    - 5.2.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.2.4 Powder
    - 5.2.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.2.5 Pills
    - 5.2.2.5.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.2.3 Liquid oral drugs
  - 5.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.3.2 Syrups
    - 5.2.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.3.3 Solutions
    - 5.2.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.2.4 Semi-solid oral drugs
  - 5.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.4.2 Gels
    - 5.2.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.4.3 Emulsions
    - 5.2.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.4.4 Elixirs
    - 5.2.4.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Injectable drug delivery
- 5.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.3.2 Conventional injection devices
  - 5.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.2.2 By material
    - 5.3.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.2.2 Glass syringes
    - 5.3.2.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.2.3 Plastic syringes
    - 5.3.2.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.2.3 By product
    - 5.3.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.3.2 Fillable syringes
    - 5.3.2.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.3.3 Prefilled syringes
    - 5.3.2.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.2.4 By usability
    - 5.3.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.4.2 Reusable syringes
    - 5.3.2.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.4.3 Disposable syringes
    - 5.3.2.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.3.3 Self-injection devices
  - 5.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.3.2 Needle-free injectors
    - 5.3.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.3.3 Autoinjectors
    - 5.3.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.3.4 Pen injectors
    - 5.3.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.3.5 Wearable injectors
    - 5.3.3.5.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.3.4 Other injector devices
  - 5.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 Topical drug delivery
- 5.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4.2 Liquid formulations
  - 5.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.2.2 Solutions
    - 5.4.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.2.3 Suspensions
    - 5.4.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4.3 Semi-solid formulations
  - 5.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.2 Creams
    - 5.4.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.3 Gels
    - 5.4.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.4 Ointments
    - 5.4.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.5 Pastes
    - 5.4.3.5.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.6 Lotions
    - 5.4.3.6.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4.4 Solid formulations
  - 5.4.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.4.2 Suppositories
    - 5.4.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.4.3 Powders
    - 5.4.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4.5 Transdermal products
  - 5.4.5.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.5.2 Transdermal patches
    - 5.4.5.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.5.3 Transdermal gels
    - 5.4.5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Ocular drug delivery
- 5.5.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.5.2 Liquid formulations
  - 5.5.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.2.2 Eye drops
    - 5.5.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.2.3 Liquid sprays
    - 5.5.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.5.3 Semi-solid formulations
  - 5.5.3.2 Gels
    - 5.5.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.3.3 Eye ointments
    - 5.5.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.5.4 Ocular devices
  - 5.5.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.4.2 Drug-coated contact lenses
    - 5.5.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.4.3 Ocular inserts
    - 5.5.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.6 Pulmonary drug delivery
- 5.6.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.6.2 Metered-dose inhalers
  - 5.6.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.6.3 Dry powder inhalers
  - 5.6.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.6.4 Nebulizers
  - 5.6.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.6.4.2 Jet nebulizers
    - 5.6.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.6.4.3 Ultrasonic nebulizers
    - 5.6.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.6.4.4 Soft mist nebulizers
    - 5.6.4.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.7 Nasal drug delivery
- 5.7.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.7.2 Nasal drops
  - 5.7.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.7.3 Nasal sprays
  - 5.7.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.7.4 Nasal powders
  - 5.7.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.7.5 Nasal gels
  - 5.7.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.8 Transmucosal drug delivery
- 5.8.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.8.2 Oral formulations
  - 5.8.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.8.2.2 Buccal drug delivery
    - 5.8.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.8.2.3 Sublingual drug delivery
    - 5.8.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.8.3 Other transmucosal drug delivery technologies
  - 5.8.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.8.3.2 Rectal drug delivery
    - 5.8.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.8.3.3 Vaginal drug delivery
    - 5.8.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.9 Implantable drug delivery
- 5.9.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.9.2 Active implantable drug delivery
  - 5.9.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.9.3 Passive implantable drug delivery
  - 5.9.3.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Pharmaceutical Drug Delivery Market, By Application

6.1 Key segment trends
6.2 Infectious diseases
- 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Cancer
- 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Cardiovascular diseases
- 6.4.1 Market size, by region, 2018 - 2032 (USD Million)
6.5 Diabetes
- 6.5.1 Market size, by region, 2018 - 2032 (USD Million)
6.6 Respiratory diseases
- 6.6.1 Market size, by region, 2018 - 2032 (USD Million)
6.7 Central nervous system disorders
- 6.7.1 Market size, by region, 2018 - 2032 (USD Million)
6.8 Autoimmune diseases
- 6.8.1 Market size, by region, 2018 - 2032 (USD Million)
6.9 Other applications
- 6.9.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Pharmaceutical Drug Delivery Market, By Facility of Use

7.1 Key segment trends
7.2 Hospitals
- 7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Ambulatory surgical centers and clinics
- 7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Home care settings
- 7.4.1 Market size, by region, 2018 - 2032 (USD Million)
7.5 Diagnostic centers
- 7.5.1 Market size, by region, 2018 - 2032 (USD Million)
7.6 Other facilities of use
- 7.6.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 8 Pharmaceutical Drug Delivery Market, By Region

8.1 Key regional trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Switzerland
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

9.1 Pfizer Inc.
9.2 Johnson & Johnson
9.3 AbbVie Inc.
9.4 Merck & Co., Inc.
9.5 Sanofi
9.6 Bayer AG
9.7 Amgen, Inc
9.8 AstraZeneca plc
9.9 Eli Lilly and Company
9.10 Gilead Science, Inc.

Pharmaceutical Drug Delivery Market - By Route Of Administration, By Application, Facility Of Use - Global Forecast to 2032